HomepageHNSPF • OTCMKTS
add
Hansoh Pharmaceutical Group Company Ltd
Vorige slotkoers
$ 3,45
Jaar-range
$ 1,95 - $ 5,58
Beurswaarde
145,11 mld. HKD
Gem. volume
50,00
Koers/winst
-
Dividendrendement
-
Primaire beurs
HKG
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 2,88 mld. | 2,91% |
Bedrijfskosten | 1,96 mld. | 13,40% |
Netto inkomsten | 823,15 mln. | -17,22% |
Netto winstmarge | 28,60 | -19,57% |
Winst per aandeel | — | — |
EBITDA | 739,07 mln. | -18,16% |
Effectief belastingtarief | 16,30% | — |
Balans
Totale activa
Totale passiva
| (CNY) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 23,39 mld. | -6,02% |
Totale activa | 31,66 mld. | -4,18% |
Totale passiva | 2,98 mld. | -58,89% |
Totaal aandelenvermogen | 28,68 mld. | — |
Uitstaande aandelen | 5,93 mld. | — |
Koers-boekwaardeverhouding | 0,71 | — |
Rendement op activa | 5,15% | — |
Rendement op kapitaal | 5,67% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 823,15 mln. | -17,22% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Opgericht
1995
Website
Werknemers
8.989
